InvestorsHub Logo

ATLnsider

04/20/23 10:07 AM

#587261 RE: hyperopia #587258

hyperopia, thank you for sharing all of that information.
Bullish
Bullish

sukus

04/20/23 10:20 AM

#587269 RE: hyperopia #587258

Regulators love this.

flipper44

04/20/23 10:22 AM

#587270 RE: hyperopia #587258

Thank you Hyperopia.

dstock07734

04/20/23 11:05 AM

#587285 RE: hyperopia #587258

Post like this shines my day!
Thanks.

ATLnsider

04/20/23 11:26 AM

#587300 RE: hyperopia #587258

hyperopia, I had a chance to go through Autolomous‘ website, and they specifically mentioned that their AutoloMATE eBMR software is currently being used to automate the production of an autologous DC Vaccine, and they list Advent Bioservices as a customers.

It’s obvious to me that they are working with NWBio, and their software is being used to manufacture DCVax-L. This bodes well for the DCVax-L commercialization launch, and subsequent manufacturing scale-up in the UK and the EU. Kudos to Linda Powers, and the NWBio and Advent senior management teams for being proactive and visionary in this regard:



Bullish
Bullish

dmb2

04/20/23 1:38 PM

#587387 RE: hyperopia #587258

hyperopia, thx for the info on the batch software, good to know Advent is completely meeting current RA processing expectations with current edge technology. This type of system could most likely operate in hybrid mode with semi-manual processing or in full automation mode with Flaskworks, which is optimal. I am hopeful the upcoming approval process includes Flaskworks, and if so, I am ok with their timeline performance.